Bausch Health Companies Inc. (FRA:BVF)

Market Cap	1.79B -33.8%
Revenue (ttm)	8.55B +5.9%
Net Income	308.53M
EPS	0.82
Shares Out	n/a
PE Ratio	5.80
Forward PE	1.36
Dividend	n/a
Ex-Dividend Date	n/a

Volume	500
Average Volume	73
Open	4.454
Previous Close	4.512
Day's Range	4.454 - 4.471
52-Week Range	3.986 - 7.000
Beta	n/a
RSI	28.03
Earnings Date	Feb 18, 2026

About Bausch Health Companies

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products. The Intern...

• Industry: Pharmaceutical Preparations
• CEO: Thomas Appio
• Employees: 20,700
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: BVF

Financial Performance

In 2024, Bausch Health Companies's revenue was $9.63 billion, an increase of 9.91% compared to the previous year's $8.76 billion. Losses were -$46.00 million, -92.23% less than in 2023.

Financial numbers in USD